PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE anti-mouse/human CD351 (Fcα/µ receptor), 200 μg
PE anti-mouse/human CD44, 100 tests
PE anti-mouse/human CD44, 200 μg
PE anti-mouse/human CD44, 25 tests
PE anti-mouse/human CD44, 50 μg
PE anti-mouse/human CD45R/B220, 200 μg
PE anti-mouse/human CD45R/B220, 50 μg
PE anti-mouse/human GL7 Antigen (T and B cell Activation Marker), 100 μg
PE anti-mouse/human GL7 Antigen (T and B cell Activation Marker), 25 μg
PE anti-mouse/human Helios, 100 tests
PE anti-mouse/human Helios, 25 tests
PE anti-mouse/human KLRG1 (MAFA), 100 μg
PE anti-mouse/human KLRG1 (MAFA), 25 μg
PE anti-mouse/human Mac-2 (Galectin-3), 200 μg
PE anti-mouse/human Mac-2 (Galectin-3), 50 μg
PE anti-mouse/human SEMA4A, 100 μg